News

NATCO launches Chlorantraniliprole (CTPR) formulated product NATGEN

NATCO estimates the current market size of CTPR containing products in India to be over Rs. 2,000 crore.

  • By IPP Bureau | September 26, 2022

Natco Pharma Limited has launched Chlorantraniliprole (CTPR) 18.5% SC under the Brand Name of NATGEN in the Indian Market.

NATCO estimates the current market size of CTPR containing products in India to be over Rs. 2,000 crore.

Upcoming E-conference

ChemPharma R&D Summit 2026

October 27, 2026

Other Related stories

Startup

Digitization